WILLIAM CANCE MD

Dr. Cance is a surgical oncologist and professor of Pharmacology and Toxicology at the University of Arizona, as well as a Distinguished Scientist at GRAIL.

As an advisor on the project, he brings a wealth of knowledge and experience; he has studied FAK and its role in cancer since the 1990s. His lab was the first to clone the human gene for the protein and to demonstrate overexpression in invasive and metastatic tumors, and he is the principal investigator for a 25-year National Cancer Institute (NCI) grant focused on FAK.

He holds eight patents and has participated in multiple entrepreneurial projects to bring his research advances to market. Dr. Cance received his medical degree and a BS in Zoology from Duke University. He completed a residency in general surgery at Barnes-Jewish Hospital/Washington University School of Medicine and a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center.